DeepMed Research

Alliance for Clinical Trials in Oncology

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 2011-01-01

Employees: 251

Market Cap: -

Website: https://www.allianceforclinicaltrialsinoncology.org

Clinical Trials

Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy

Phase 3

Completed

Conditions: Malignant Neoplasm

Interventions: Drug: Palonosetron Hydrochloride
Drug: Ondansetron Hydrochloride
Drug: Dexamethasone
Drug: Fosaprepitant Dimeglumine
Other: Placebo
Drug: Olanzapine

First Posted Date: 2018-07-05

Last Posted Date: 2025-04-06

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 690

Registration Number: NCT03578081

Locations: 🇺🇸
Prisma Health Cancer Institute - Easley, Easley, South Carolina, United States
🇺🇸
Hurley Medical Center, Flint, Michigan, United States
🇺🇸
Saint Alphonsus Cancer Care Center-Boise, Boise, Idaho, United States

and more 562 locations

Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients with Stage IIa-IIIa Breast Cancer

Phase 3

Active, not recruiting

Conditions: Invasive Breast Carcinoma
Lobular Breast Carcinoma
Stage IIIA Breast Cancer
Tubular Breast Carcinoma
Ductal Breast Carcinoma
Medullary Breast Carcinoma
Stage IIA Breast Cancer
Stage IIB Breast Cancer
Stage II Breast Cancer

Interventions: Radiation: Radiation Therapy
Other: Questionnaire Administration
Other: Quality-of-Life Assessment
Other: Laboratory Biomarker Analysis
Radiation: Hypofractionated Radiation Therapy

First Posted Date: 2018-01-30

Last Posted Date: 2025-01-17

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 897

Registration Number: NCT03414970

Locations: 🇺🇸
Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States
🇺🇸
Anchorage Radiation Therapy Center, Anchorage, Alaska, United States
🇺🇸
Alaska Breast Care and Surgery LLC, Anchorage, Alaska, United States

and more 854 locations

Vemurafenib and Cobimetinib in Treating Patients with BRAF V600E Mutation Positive Craniopharyngioma

Phase 2

Active, not recruiting

Conditions: BRAF V600E Mutation Present
Papillary Craniopharyngioma

Interventions: Drug: Vemurafenib
Drug: Cobimetinib
Other: Laboratory Biomarker Analysis
Other: Quality-of-Life Assessment

First Posted Date: 2017-07-21

Last Posted Date: 2025-02-18

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 24

Registration Number: NCT03224767

Locations: 🇺🇸
Alta Bates Summit Medical Center-Herrick Campus, Berkeley, California, United States
🇺🇸
Palo Alto Medical Foundation-Camino Division, Mountain View, California, United States
🇺🇸
UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States

and more 103 locations

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Phase 3

Suspended

Conditions: B Acute Lymphoblastic Leukemia

Interventions: Drug: Allopurinol
Drug: Cytarabine
Drug: Daunorubicin Hydrochloride
Drug: Vincristine Sulfate
Drug: Dexamethasone
Drug: Pegylated L-Asparaginase
Drug: Methotrexate
Procedure: Bone Marrow Aspiration and Biopsy
Drug: Cyclophosphamide
Drug: Mercaptopurine
Biological: Rituximab
Drug: Thioguanine
Drug: Doxorubicin
Other: Laboratory Biomarker Analysis
Biological: Inotuzumab Ozogamicin

First Posted Date: 2017-05-12

Last Posted Date: 2025-04-02

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 310

Registration Number: NCT03150693

Locations: 🇺🇸
University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
🇺🇸
Katmai Oncology Group, Anchorage, Alaska, United States
🇺🇸
Fairbanks Memorial Hospital, Fairbanks, Alaska, United States

and more 456 locations

Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer

Phase 3

Completed

Conditions: Stage IIA Prostate Cancer
PSA Level Ten to Fifty
PSA Level Five to Ten
Stage II Prostate Cancer
Stage IIB Prostate Cancer
Stage III Prostate Cancer
Stage I Prostate Cancer
PSA Level Less Than Five

Interventions: Other: Internet-Based Intervention
Other: Best Practice
Other: Quality-of-Life Assessment
Other: Questionnaire Administration
Other: Survey Administration
Other: Laboratory Biomarker Analysis

First Posted Date: 2017-04-06

Last Posted Date: 2025-01-27

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 158

Registration Number: NCT03103321

Locations: 🇺🇸
Kaiser Permanente-Cadillac, Los Angeles, California, United States
🇺🇸
University of New Mexico Cancer Center, Albuquerque, New Mexico, United States
🇺🇸
John H Stroger Jr Hospital of Cook County, Chicago, Illinois, United States

and more 25 locations

Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

Phase 2

Terminated

Conditions: Stage IIIB Non-Small Cell Lung Cancer
Stage IV Non-small Cell Lung Cancer

Interventions: Drug: Naloxegol
Other: Placebo
Other: Laboratory Biomarker Analysis
Other: Quality-of-Life Assessment

First Posted Date: 2017-03-22

Last Posted Date: 2025-02-03

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 50

Registration Number: NCT03087708

Locations: 🇺🇸
Mount Carmel East Hospital, Columbus, Ohio, United States
🇺🇸
Columbus Oncology and Hematology Associates Inc, Columbus, Ohio, United States
🇺🇸
Grant Medical Center, Columbus, Ohio, United States

and more 656 locations

Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy

Phase 3

Terminated

Conditions: Node Positive HER2 Negative Breast Cancer

Interventions: Other: Placebo
Drug: Aspirin

First Posted Date: 2016-10-07

Last Posted Date: 2023-04-05

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 3021

Registration Number: NCT02927249

Locations: 🇺🇸
Contra Costa Regional Medical Center, Martinez, California, United States
🇺🇸
Ascension Providence Hospitals - Novi, Novi, Michigan, United States
🇺🇸
Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro, Arkansas, United States

and more 1442 locations

Pulmonary Rehabilitation Before Lung Cancer Resection

Phase 3

Terminated

Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Non-small Cell Lung Cancer (NSCLC)

Interventions: Other: education
Device: pedometer
Procedure: rehabilitation
Procedure: surgery

First Posted Date: 2016-09-02

Last Posted Date: 2025-02-03

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 9

Registration Number: NCT02887521

Locations: 🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States
🇺🇸
Saint Vincent Hospital Cancer Center Green Bay, Green Bay, Wisconsin, United States
🇨🇦
London Regional Cancer Program, London, Ontario, Canada

and more 4 locations

Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes

Phase 3

Terminated

Conditions: Lung Carcinoma

Interventions: Drug: Placebo
Drug: Varenicline
Other: Tobacco Cessation Counseling

First Posted Date: 2016-08-05

Last Posted Date: 2022-07-27

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 23

Registration Number: NCT02856581

Locations: 🇺🇸
Baptist Health Paducah, Paducah, Kentucky, United States
🇺🇸
Bhadresh Nayak MD PC-Sterling Heights, Sterling Heights, Michigan, United States
🇺🇸
Coborn Cancer Center at Saint Cloud Hospital, Saint Cloud, Minnesota, United States

and more 371 locations

Combination Chemotherapy With or Without Hypofractionated Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer

Phase 2

Conditions: Pancreatic Adenocarcinoma
Borderline Resectable Adenocarcinoma of the Head of the Pancrease

Interventions: Procedure: surgery
Radiation: radiation therapy
Drug: mFOLFIRINOX
Drug: FOLFOX

First Posted Date: 2016-07-20

Last Posted Date: 2022-05-24

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 126

Registration Number: NCT02839343

Locations: 🇺🇸
Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina, United States
🇺🇸
Levine Cancer Institute-SouthPark, Charlotte, North Carolina, United States
🇺🇸
Levine Cancer Institute-Mallard Creek, Charlotte, North Carolina, United States

and more 152 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy